Applied Genetic Technologies (AGTC) Misses Q3 EPS by 4c
Get Alerts AGTC Hot Sheet
Join SI Premium – FREE
Applied Genetic Technologies (NASDAQ: AGTC) reported Q3 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $5.57 million.
For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- Minerals Technologies (MTX) Tops Q3 EPS by 2c
- Peoples Financial Corp/ms (PFBX) Tops Q3 EPS by 24c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share